Scott J. Hunter, PhD, a member of WCG’s Scientific Leadership Team, shared his insights during a recent conversation with Mark Opler, PhD, MPH, chief research officer at WCG’s MedAvante-ProPhase. Dr. Hunter is a professor of psychiatry and behavioral neuroscience, as well as pediatrics, at the University of Chicago.
Request a Genetics in Clinical Trials training session
What You'll LearnMost Recent Flipbooks
Ideal vs. Reality Budgeting - Create & Negotiate the Best Clinical Trial Budget for Your Site
No Longer an Afterthought - A Call for Greater Diversity and Inclusion in Clinical Trials
